Nurse Practitioner Program year 2023 Reported 2021–2023 Source: CMS Open Payments, 2026 publication

Lonniel Bain

Nurse Practitioner, Family Madison, WI Nurse Practitioner

NPI 1548309495 CMS profile 10814225

5505 Endeavor Ln, Madison, WI 53719

Open in the dashboard

General payments

$54,289

331 records reported · program years 2021–2023

Research payments

$0

Paid to them · None reported · program years 2021–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Lonniel Bain of Madison, WI is reported in the CMS Open Payments database as having received $54,289 across 331 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $27,246 99
2022 General $13,385 130
2021 General $13,658 102

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lonniel Bain
  • Nurse Practitioner, Family median
  • Middle half of Nurse Practitioner, Family
  • National median

In program year 2025, general payments to Lonniel Bain were reported at $0. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.

Show as a table
Year Lonniel Bain Nurse Practitioner, Family median Middle half National median
2019 $0 $39 $18–$91 $163
2020 $0 $32 $17–$76 $114
2021 $13,658 $124 $35–$379 $132
2022 $13,385 $141 $44–$430 $149
2023 $27,246 $154 $49–$476 $160
2024 $0 $165 $51–$504 $164
2025 $0 $168 $53–$521 $169

Breakdown

Who paid General payments · program years 2021–2023
  1. E.R. Squibb & Sons, L.L.C. $25,209 64 payments
  2. AbbVie, Inc. $16,524 106 payments
  3. Janssen Biotech, Inc. $6,140 17 payments
  4. Celgene Corporation $2,701 27 payments
  5. Ironwood Pharmaceuticals, Inc $1,588 11 payments
  6. Salix Pharmaceuticals, a division of Bausch Health US, LLC $743 38 payments
  7. Takeda Pharmaceuticals U.S.A., Inc. $361 22 payments
  8. Ardelyx, Inc. $276 10 payments
  9. Janssen Scientific Affairs, LLC $147 4 payments
  10. Gilead Sciences, Inc. $133 7 payments
  11. Other $467 25 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,507 41 payments
  2. Travel and Lodging $8,117 42 payments
  3. Food and Beverage $6,423 243 payments
  4. Consulting Fee $2,160 3 payments
  5. Education $82 2 payments
Products named General payments · program years 2021–2023
  1. ZEPOSIA $26,110 89 payments
  2. STELARA $6,287 21 payments
  3. LINZESS Gastroenterology $5,775 50 payments
  4. CREON $5,370 32 payments
  5. RINVOQ $3,360 15 payments
  6. SKYRIZI $1,874 8 payments
  7. Linzess Gi $1,588 11 payments
  8. TRULANCE $590 27 payments
  9. ENTYVIO $315 19 payments
  10. IBSRELA $276 10 payments
  11. Other $1,154 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

331 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Family in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record